Critical Review: Autonomix Medical (AMIX) and Its Peers

Autonomix Medical (NASDAQ:AMIX) is one of 237 publicly-traded companies in the “Surgical & medical instruments” industry, but how does it contrast to its peers? We will compare Autonomix Medical to related companies based on the strength of its analyst recommendations, institutional ownership, dividends, valuation, earnings, profitability and risk.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Autonomix Medical and its peers, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Autonomix Medical	0	0	1	0	3.00
Autonomix Medical Competitors	1940	4950	9211	272	2.48

Autonomix Medical currently has a consensus target price of $28.00, indicating a potential upside of 788.89%. As a group, “Surgical & medical instruments” companies have a potential upside of 18.70%. Given Autonomix Medical’s stronger consensus rating and higher probable upside, analysts clearly believe Autonomix Medical is more favorable than its peers.

Valuation & Earnings

This table compares Autonomix Medical and its peers top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Autonomix Medical	N/A	-$15.43 million	-0.20
Autonomix Medical Competitors	$1.03 billion	$10.01 million	-7.23

Autonomix Medical’s peers have higher revenue and earnings than Autonomix Medical. Autonomix Medical is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Profitability

This table compares Autonomix Medical and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Autonomix Medical	N/A	-542.11%	-236.92%
Autonomix Medical Competitors	-574.36%	-156.80%	-27.37%

Insider and Institutional Ownership

10.8% of Autonomix Medical shares are owned by institutional investors. Comparatively, 47.7% of shares of all “Surgical & medical instruments” companies are owned by institutional investors. 32.4% of Autonomix Medical shares are owned by company insiders. Comparatively, 15.3% of shares of all “Surgical & medical instruments” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Autonomix Medical Company Profile

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.